• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔鳞状细胞癌患者同步放化疗相关的口腔病变

Concomitant-chemoradiotherapy-associated oral lesions in patients with oral squamous-cell carcinoma.

作者信息

Minhas Sadia, Kashif Muhammad, Altaf Wasif, Afzal Nadeem, Nagi Abdul Hanan

机构信息

Oral Pathology Department, Akhtar Saeed Medical and Dental College, Lahore 54000, Pakistan.

出版信息

Cancer Biol Med. 2017 May;14(2):176-182. doi: 10.20892/j.issn.2095-3941.2016.0096.

DOI:10.20892/j.issn.2095-3941.2016.0096
PMID:28607808
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5444929/
Abstract

OBJECTIVE

: Oral squamous-cell carcinoma (OSCC) accounts for >90% of oral cancers affecting adults mostly between the fourth to seventh decades of life. The most common OSCC treatment is concomitant chemoradiotherapy (CCRT) having both loco-regional and distant control, but CCRT has acute and chronic toxic effects on adjacent normal tissue. This study aimed to determine the side effects of CCRT on the oral mucosa and to characterize the clinicopathology of oral lesions in patients with OSCC.

METHODS

This descriptive, cross-sectional study was certified by the Ethical Review Committee (UHS/Education/126-12/2728) of the University of Health Sciences, Lahore, Pakistan. OSSC patients (=81) with various histological subtypes, grades, and stages were recruited, and findings on their oral examination were recorded. These patients received 70, 90, and 119 Gy of radiotherapy dosages in combination with the chemotherapy drugs cisplatin and 5-fluorouracil. Data were analyzed using SPSS 20.0.

RESULTS

: The most common presentation of OSCC was a nonhealing ulcer (63%) involving tongue (55.6%). Clinical findings included mucositis (92.6%) and xerostomia of mild, moderate, and severe degrees in 11.1%, 46.9%, and 35.8% cases, respectively. Ulcers (87.7%), palpable lymph nodes (64.2%), limited mouth opening (64.2%) and fistula (40.7%) were also observed. In females, the association of radiotherapy dosage with limited mouth opening, xerostomia, and histological grading was statistically significant (<0.05). The association of chemotherapy drugs with xerostomia (=0.003) was also statistically significant.

CONCLUSIONS

: CCRT induced mucositis, xerostomia, and trismus in patients with OSCC.

摘要

目的

口腔鳞状细胞癌(OSCC)占影响成年人的口腔癌的90%以上,主要发生在40至70岁之间。OSCC最常见的治疗方法是同步放化疗(CCRT),它对局部和远处都有控制作用,但CCRT对相邻正常组织有急性和慢性毒性作用。本研究旨在确定CCRT对口腔黏膜的副作用,并对OSCC患者口腔病变的临床病理特征进行描述。

方法

这项描述性横断面研究得到了巴基斯坦拉合尔健康科学大学伦理审查委员会(UHS/教育/126 - 12/2728)的认证。招募了81例具有各种组织学亚型、分级和分期的OSCC患者,并记录他们口腔检查的结果。这些患者接受了70、90和119 Gy的放射治疗剂量,并联合化疗药物顺铂和5 - 氟尿嘧啶。使用SPSS 20.0对数据进行分析。

结果

OSCC最常见的表现是不愈合溃疡(63%),累及舌部(55.6%)。临床发现包括口腔黏膜炎(92.6%),口干程度为轻度、中度和重度的病例分别占11.1%、46.9%和35.8%。还观察到溃疡(87.7%)、可触及淋巴结(64.2%)、张口受限(64.2%)和瘘管(40.7%)。在女性中,放射治疗剂量与张口受限、口干和组织学分级之间的关联具有统计学意义(<0.05)。化疗药物与口干之间的关联(=0.003)也具有统计学意义。

结论

CCRT可导致OSCC患者出现口腔黏膜炎、口干和张口受限。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b95/5444929/5c1fc5b439b2/cbm-14-2-176-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b95/5444929/ca0232f5a2f7/cbm-14-2-176-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b95/5444929/9c233ab9b132/cbm-14-2-176-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b95/5444929/c5d9e3a6c8f2/cbm-14-2-176-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b95/5444929/b597b3388e81/cbm-14-2-176-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b95/5444929/83a0289da3e9/cbm-14-2-176-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b95/5444929/5c1fc5b439b2/cbm-14-2-176-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b95/5444929/ca0232f5a2f7/cbm-14-2-176-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b95/5444929/9c233ab9b132/cbm-14-2-176-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b95/5444929/c5d9e3a6c8f2/cbm-14-2-176-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b95/5444929/b597b3388e81/cbm-14-2-176-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b95/5444929/83a0289da3e9/cbm-14-2-176-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b95/5444929/5c1fc5b439b2/cbm-14-2-176-6.jpg

相似文献

1
Concomitant-chemoradiotherapy-associated oral lesions in patients with oral squamous-cell carcinoma.口腔鳞状细胞癌患者同步放化疗相关的口腔病变
Cancer Biol Med. 2017 May;14(2):176-182. doi: 10.20892/j.issn.2095-3941.2016.0096.
2
Assessment and prevalence of concomitant chemo-radiotherapy-induced oral mucositis in patients with oral squamous cell carcinoma.评估和口腔鳞状细胞癌患者同期放化疗诱导的口腔黏膜炎的流行情况。
Turk J Med Sci. 2021 Apr 30;51(2):675-684. doi: 10.3906/sag-2007-131.
3
A Cytological Study Enlightening the Unseen Effects of Concomitant Chemoradiotherapy in Contralateral Normal Buccal Mucosa of Oral Squamous Cell Carcinoma Patients.一项细胞学研究揭示口腔鳞状细胞癌患者对侧正常颊黏膜同步放化疗的潜在影响
Cureus. 2021 Apr 14;13(4):e14483. doi: 10.7759/cureus.14483.
4
Evaluation of recurrence, mortality and treatment complications of oral squamous cell carcinoma in public health centers in Shiraz during 2010 to 2020.2010 年至 2020 年在设拉子公共卫生中心评估口腔鳞状细胞癌的复发、死亡率和治疗并发症。
BMC Oral Health. 2023 May 30;23(1):341. doi: 10.1186/s12903-023-03071-2.
5
Effects of postoperative chemotherapy and radiotherapy on patients with squamous cell carcinoma of the oral cavity and multiple regional lymph node metastases.术后化疗和放疗对口腔鳞状细胞癌伴多发区域淋巴结转移患者的影响。
Int J Oral Maxillofac Surg. 2014 Jun;43(6):680-5. doi: 10.1016/j.ijom.2013.11.013. Epub 2013 Dec 30.
6
Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma.新辅助化疗后序贯同步放化疗治疗局部晚期鼻咽癌。
Chin J Cancer. 2010 May;29(5):551-5. doi: 10.5732/cjc.009.10518.
7
Postoperative adjuvant therapy for patients with loco-regionally advanced oral squamous cell carcinoma who are at high risk of recurrence.局部晚期口腔鳞状细胞癌高复发风险患者的术后辅助治疗。
Int J Oral Maxillofac Surg. 2020 Jul;49(7):848-853. doi: 10.1016/j.ijom.2019.12.007. Epub 2020 Jan 8.
8
Efficacy of elemental diet on prevention for chemoradiotherapy-induced oral mucositis in patients with oral squamous cell carcinoma.要素饮食对口腔鳞状细胞癌患者放化疗所致口腔黏膜炎的预防效果
Support Care Cancer. 2016 Feb;24(2):953-959. doi: 10.1007/s00520-015-2866-7. Epub 2015 Aug 7.
9
[Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].[同步放化疗治疗晚期宫颈鳞状细胞癌患者远处转移的结局及预后因素]
Zhonghua Fu Chan Ke Za Zhi. 2015 Feb;50(2):125-30.
10
A review of 640 Oral squamous cell carcinoma cases in Nigeria.对尼日利亚640例口腔鳞状细胞癌病例的回顾。
J Clin Exp Dent. 2017 Jun 1;9(6):e767-e771. doi: 10.4317/jced.53680. eCollection 2017 Jun.

引用本文的文献

1
A bibliometric analysis of immune response in oral cancer.口腔癌免疫反应的文献计量分析
Discov Oncol. 2025 Feb 10;16(1):146. doi: 10.1007/s12672-025-01912-w.
2
The prevalence of oral mucositis after radiotherapy in patients with Head and Neck Cancer and its associated factors: a meta-analysis.头颈部癌患者放疗后口腔黏膜炎的患病率及其相关因素:一项荟萃分析。
Clin Transl Oncol. 2025 Apr;27(4):1767-1778. doi: 10.1007/s12094-024-03706-y. Epub 2024 Sep 14.
3
SOX2 promotes a cancer stem cell-like phenotype and local spreading in oral squamous cell carcinoma.

本文引用的文献

1
The magnitude of tobacco smoking-betel quid chewing-alcohol drinking interaction effect on oral cancer in South-East Asia. A meta-analysis of observational studies.东南亚地区烟草使用、咀嚼槟榔、饮酒与口腔癌相互作用影响的幅度:观察性研究的荟萃分析。
PLoS One. 2013 Nov 18;8(11):e78999. doi: 10.1371/journal.pone.0078999. eCollection 2013.
2
Mandibular bone changes induced by head and neck radiotherapy.头颈部放疗引起的下颌骨变化
Indian J Dent Res. 2012 Nov-Dec;23(6):774-7. doi: 10.4103/0970-9290.111258.
3
Survival pattern and prognostic factors of patients with squamous cell carcinoma of the tongue: a retrospective analysis of 210 cases.
SOX2 促进口腔鳞状细胞癌中的癌症干细胞样表型和局部扩散。
PLoS One. 2023 Dec 14;18(12):e0293475. doi: 10.1371/journal.pone.0293475. eCollection 2023.
4
Innovative Metal-Organic Frameworks for Targeted Oral Cancer Therapy: A Review.用于靶向口腔癌治疗的创新金属有机框架:综述
Materials (Basel). 2023 Jun 29;16(13):4685. doi: 10.3390/ma16134685.
5
Polydopamine surface-modified hyperbranched polymeric nanoparticles for synergistic chemo/photothermal therapy of oral cancer.聚多巴胺表面修饰的超支化聚合物纳米颗粒用于口腔癌的协同化学/光热治疗
Front Bioeng Biotechnol. 2023 May 5;11:1174014. doi: 10.3389/fbioe.2023.1174014. eCollection 2023.
6
pH-responsive graphene oxide loaded with targeted peptide and anticancer drug for OSCC therapy.负载靶向肽和抗癌药物的pH响应性氧化石墨烯用于口腔鳞状细胞癌治疗。
Front Oncol. 2022 Aug 3;12:930920. doi: 10.3389/fonc.2022.930920. eCollection 2022.
7
Prevalence of hyposalivation and associated factors in survivors of head and neck cancer treated with radiotherapy.接受放射治疗的头颈癌幸存者中唾液分泌减少的患病率及相关因素
J Appl Oral Sci. 2021 Apr 19;29:e20200854. doi: 10.1590/1678-7757-2020-0854. eCollection 2021.
8
The relationship between TNF-α gene promoter polymorphism (- 1211 T > C), the plasma concentration of TNF-α, and risk of oral mucositis and shortening of overall survival in patients subjected to intensity-modulated radiation therapy due to head and neck cancer.TNF-α 基因启动子多态性(-1211T>C)、TNF-α 血浆浓度与头颈部癌调强放疗患者口腔黏膜炎风险及总生存时间缩短的关系。
Support Care Cancer. 2020 Feb;28(2):531-540. doi: 10.1007/s00520-019-04838-6. Epub 2019 May 10.
舌鳞状细胞癌患者的生存模式及预后因素:210例回顾性分析
J Oral Maxillofac Surg. 2013 Apr;71(4):775-85. doi: 10.1016/j.joms.2012.09.026. Epub 2012 Dec 23.
4
Squamous cell carcinoma of the oral cavity and the oropharynx in patients less than 40 years of age: a 20-year analysis.40岁以下患者口腔和口咽鳞状细胞癌:一项20年的分析
Head Neck Oncol. 2012 May 30;4:28. doi: 10.1186/1758-3284-4-28.
5
Characterization of Yemeni patients treated for oral and pharyngeal cancers in Saudi Arabia.在沙特阿拉伯接受口腔和咽喉癌治疗的也门患者特征分析。
Saudi Med J. 2011 Nov;32(11):1177-82.
6
Factors related to late stage diagnosis of oral squamous cell carcinoma.与口腔鳞状细胞癌晚期诊断相关的因素。
Med Oral Patol Oral Cir Bucal. 2012 Jan 1;17(1):e35-40. doi: 10.4317/medoral.17399.
7
Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years.18 至 44 岁的年轻白人女性中口腔舌鳞状细胞癌发病率上升。
J Clin Oncol. 2011 Apr 10;29(11):1488-94. doi: 10.1200/JCO.2010.31.7883. Epub 2011 Mar 7.
8
CCND1 amplification and protein overexpression in oral squamous cell carcinoma of young patients.CCND1 扩增和蛋白过表达与年轻患者口腔鳞状细胞癌的关系。
Head Neck. 2011 Oct;33(10):1413-9. doi: 10.1002/hed.21618. Epub 2011 Jan 20.
9
Limited mouth opening after primary therapy of head and neck cancer.头颈癌初次治疗后张口受限。
Oral Maxillofac Surg. 2010 Sep;14(3):169-73. doi: 10.1007/s10006-010-0220-2.
10
Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications.口腔鳞状细胞癌:当前对病因发病机制及临床意义的认识概述
Oral Dis. 2009 Sep;15(6):388-99. doi: 10.1111/j.1601-0825.2009.01563.x. Epub 2009 Apr 2.